- Issuer ticker
-
FENC
- Reported as of
-
31 Oct 2024
- Net transaction value
-
$0
- SEC form
-
4
- Accepted by SEC
-
04 Nov 2024, 17:30:05 UTC
Filing notes and source
Key filing fact
Robert Andrade filed Form 4 for FENNEC PHARMACEUTICALS INC. (FENC) on 04 Nov 2024.
Key facts
- This page summarizes Robert Andrade's Form 4 filing for FENNEC PHARMACEUTICALS INC. (FENC).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 04 Nov 2024, 17:30.
Change
- Previous filing in this sequence was filed on 01 Oct 2024.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
Ownership activity is grounded in SEC Form 4 disclosures.
View source filing
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
FENC
transaction
Common shares
Award
- Transaction value
- $0
- Shares
- +1,042
- Change %
- +0.94%
- Price
-
$0.000000
- Shares after
- 111,565
- Date
- 31 Oct 2024
- Ownership
- Direct
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Explanation of responses
1 footnote